You are here

  • Home
  • Archive
  • Volume 76, Issue 1
  • Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Article metrics

Article menu
XML
Clinical and epidemiological research
Extended report
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

 

Online download statistics by month:

Online download statistics by month: September 2016 to April 2023

AbstractFullPdf
Sep 2016540114206
Oct 2016222111121091
Nov 201616131043692
Dec 20161549957520
Jan 20171071795509
Feb 2017167612395
Mar 20176549389
Apr 201710563395
May 20171441255
Jun 201782367353
Jul 2017314306327
Aug 2017314313216
Sep 2017285275265
Oct 2017303299287
Nov 2017426422222
Dec 2017471466253
Jan 2018584584184
Feb 2018401375166
Mar 2018733717130
Apr 2018567570140
May 2018465472264
Jun 2018549546370
Jul 2018517513219
Aug 2018499494168
Sep 2018504503181
Oct 2018614614212
Nov 2018605605190
Dec 2018450444154
Jan 2019467465169
Feb 2019552550208
Mar 2019459453185
Apr 2019387382146
May 2019371365121
Jun 2019339338115
Jul 2019316311124
Aug 2019277276123
Sep 2019263263137
Oct 2019261259151
Nov 2019398389159
Dec 2019363348115
Jan 2020327315144
Feb 2020282280109
Mar 2020332332143
Apr 2020373369173
May 2020320319143
Jun 2020215207100
Jul 2020266264139
Aug 2020206204165
Sep 2020232230127
Oct 2020227224171
Nov 2020238233150
Dec 202020620374
Jan 202123322898
Feb 202121821673
Mar 2021262262158
Apr 2021251245113
May 2021264260108
Jun 202117817982
Jul 202125724680
Aug 202123623683
Sep 202122021981
Oct 202123721885
Nov 2021265237121
Dec 202120417489
Jan 2022217184140
Feb 202218718686
Mar 202230631195
Apr 2022247264137
May 2022225245108
Jun 202215815866
Jul 202221120572
Aug 202221620588
Sep 202218218381
Oct 202216817465
Nov 202222122082
Dec 202215815376
Jan 202319518973
Feb 202321320756
Mar 202327528473
Apr 202318819082
Total297302872814695